Epitope specificity of antibody-mediated protection induced in mice by the malaria vaccine RTS,S/AS01
- PMID: 40394009
- PMCID: PMC12092751
- DOI: 10.1038/s41541-025-01162-5
Epitope specificity of antibody-mediated protection induced in mice by the malaria vaccine RTS,S/AS01
Abstract
Antibodies induced by the malaria vaccine RTS,S/AS01 neutralize infectivity of transgenic sporozoites expressing Plasmodium falciparum CSP (PfCSP). These antibodies recognize the junctional, minor repeats, central repeats, and C-term regions of this antigen. The epitope specificity of antibodies mediating protection in mice was characterized in vivo using transgenic sporozoites expressing restricted antigenic portions of PfCSP. In this model, we found protection is mediated mostly by antibodies specific for the central repeats.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: Author F.Z. serves as associate editor of this Journal and had no role in the peer review or decision to publish this manuscript. Author F.Z. declares no financial competing interest. All other authors declare no competing interests.
Figures


Similar articles
-
ProC6C, a novel multi-stage malaria vaccine, elicits functional antibodies against the minor and central repeats of the Circumsporozoite Protein in human adults.Front Immunol. 2024 Nov 1;15:1481829. doi: 10.3389/fimmu.2024.1481829. eCollection 2024. Front Immunol. 2024. PMID: 39555079 Free PMC article. Clinical Trial.
-
Structural ordering of the Plasmodium berghei circumsporozoite protein repeats by inhibitory antibody 3D11.Elife. 2020 Nov 30;9:e59018. doi: 10.7554/eLife.59018. Elife. 2020. PMID: 33253113 Free PMC article.
-
The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity.Malar J. 2016 May 31;15:301. doi: 10.1186/s12936-016-1348-9. Malar J. 2016. PMID: 27245446 Free PMC article.
-
Humoral Immune Responses to P. falciparum Circumsporozoite Protein (Pfcsp) Induced by the RTS, S Vaccine - Current Update.Infect Drug Resist. 2023 Apr 12;16:2147-2157. doi: 10.2147/IDR.S401247. eCollection 2023. Infect Drug Resist. 2023. PMID: 37077252 Free PMC article. Review.
-
Current Challenges in the Identification of Pre-Erythrocytic Malaria Vaccine Candidate Antigens.Front Immunol. 2020 Feb 21;11:190. doi: 10.3389/fimmu.2020.00190. eCollection 2020. Front Immunol. 2020. PMID: 32153565 Free PMC article. Review.
References
-
- W. H. O. W. m. r. World Health Organization. World malaria report 2022. https://www.who.int/teams/global-malaria-programme
-
- Gordon, D. M. et al. Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine. J. Infect. Dis.171, 1576–1585 (1995). - PubMed
-
- Datoo, M. S. et al. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial. Lancet403, 533–544 (2024). - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases